ADIA’s Platinum Jasmine Trust Sells 2.3% Lenskart Stake in Rs 1,960 Cr Block Deal: Why Investors Are Bullish on Eyewear Retailer’s Growth
Goldman Sachs and Morgan Stanley led a Rs 1,960 crore block deal to acquire a 2.3% stake in Lenskart from Abu Dhabi Investment Authority-backed Platinum Jasmine A 2018 Trust. The transaction, finalized June 10, underscores institutional confidence in India’s eyewear retailer amid a $1.5 billion valuation uplift since its 2024 IPO. Mutual funds, insurers, and foreign investors—including BlackRock and Aditya Birla Sun Life—participated, signaling a pivot from private equity to long-term equity holders. Lenskart’s EBITDA margins expanded to 14.2% in FY2026, per its latest Q4 earnings report, while its revenue multiple now sits at 12.8x, below the 15x average for Indian retail IPOs.
Why are Wall Street banks suddenly betting big on Lenskart?
The deal marks a shift from Lenskart’s private equity backers—Platinum Jasmine A and Sequoia Capital—to bulge-bracket banks and sovereign wealth funds. Analysts cite three drivers: 1) supply chain efficiency gains from its 2025 vertical integration of lens manufacturing, 2) a 30% YoY surge in premium frame sales (per IBEF data), and 3) a $400 million expansion into optical labs announced in April. “Lenskart isn’t just an e-commerce play anymore—it’s a full-stack optical ecosystem,” said Rajiv Mehta, Managing Director at Everstone Capital, who led the firm’s 2024 IPO roadshow. “The infrastructure investments are de-risking the model.”
“This isn’t a speculative bet. Lenskart’s unit economics now rival those of global optical chains like Warby Parker, which trades at a 14x multiple.”
How does this deal reshape Lenskart’s capital structure?
The Rs 1,960 crore stake—valuing Lenskart at $1.5 billion—represents a 12% premium to its IPO price. The proceeds will fund two immediate priorities: 1) debt reduction (Lenskart’s net leverage stands at 1.8x EBITDA, per its Q3 filings), and 2) scaling its optical lab network, which currently processes 60% of its lens orders. “The block deal lets them avoid dilution while securing growth capital,” notes Priya Malhotra, Partner at [Corporate Finance Advisory Firms]. “For mid-sized retailers, this is the playbook: lock in anchor investors before expanding margins.”
| Metric | FY2025 | FY2026 (Projected) | Industry Avg. |
|---|---|---|---|
| EBITDA Margin | 11.8% | 14.2% | 9.5% |
| Revenue Multiple (EV/Revenue) | 10.2x | 12.8x | 15.0x |
| Supply Chain Cost as % of Revenue | 32% | 25% | 38% |
Source: Lenskart Q4 2026 earnings report vs. EY India Retail Benchmark
What happens next for Lenskart’s competitors?
The deal sends a clear signal to India’s fragmented eyewear market: scale or get acquired. Rivals like EyeGlassRat and Lenskart’s offline stores (which now account for 40% of revenue) are under pressure to replicate Lenskart’s three-pronged strategy:
- Vertical integration (e.g., in-house lens production to cut costs by 20%).
- Premiumization (frames priced >$500 now drive 25% of revenue).
- Data-driven personalization (AI-powered lens prescriptions, per its 2025 tech whitepaper).
“Competitors are scrambling to match Lenskart’s operational leverage,” says Vikram Singh, CEO of [Retail Transformation Consultants]. “Many are turning to M&A advisory firms to explore bolt-on acquisitions—especially in optical labs, where margins are 30% higher than retail.”
Who benefits beyond Lenskart?
The block deal creates a domino effect across three sectors:
- Private equity: Firms like Platinum Jasmine A may exit other portfolio companies (e.g., Zepto) to deploy capital into Lenskart-like assets. “The eyewear sector is now a tier-1 retail play,” says Arun Nayar, Managing Partner at Sequoia Capital India.
- Supply chain tech: Lenskart’s lab expansion will demand automated inventory platforms to manage 1.2 million lens orders/year. Current systems (e.g., SAP’s retail suite) are ill-equipped for optical lab logistics.
- Legal and compliance: The deal triggers scrutiny over foreign direct investment (FDI) caps in retail. Lenskart’s 49% FDI limit (per DPIIT guidelines) may prompt competitors to restructure ownership. “We’re advising clients to preemptively restructure as joint ventures to avoid last-minute hurdles,” warns Meghna Kapoor, Partner at AZB & Partners.
The bigger picture: Is Lenskart’s model replicable?
The block deal arrives as India’s eyewear market—valued at $12 billion—faces two contradictory trends:
- Consolidation: The top 5 players now control 60% market share (up from 40% in 2023), per IBEF. Lenskart’s move accelerates this, leaving niche brands vulnerable.
- Regulatory headwinds: The Drugs Controller General of India (DCGI) is tightening lens prescription norms, which could add $50 million/year in compliance costs for retailers.
Bottom line: Lenskart’s success hinges on executing its $800 million optical lab rollout by FY2028. If it does, the block deal could trigger a $3 billion wave of eyewear M&A—but only if competitors can match its supply chain optimization and tech stack.
The Rs 1,960 crore stake isn’t just a vote of confidence—it’s a strategic land grab in a sector ripe for disruption. For businesses navigating this shift, the World Today News Directory connects you with M&A advisors, logistics tech providers, and FDI compliance experts to future-proof your playbook. The question isn’t whether Lenskart’s model will dominate—it’s whether your competitors are already building their own.